Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to cancer treatment and radiation oncology.
Duration: August 1, 2021
to
present
General Issues: Medicare/Medicaid , Health Issues
Spending: about $940,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2021: House of Representatives, U.S. Senate, Health & Human Services - Dept of (HHS), Executive Office of the President (EOP)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Cookab Hashemi Chief of Staff, Rep. Raul Ruiz; Chief of Staff, Rep. Jackie Speier; Deputy Chief of Staff, Rep. Mark Udall; Spec Assistant, Sen. Evan Bayh; Confidential Assistant, Office of Rural Development, USDA; Spec Assistant, Ofc of Political Affairs, White Hse
Dan Elling Staff Director, Ways and Means Health Subcommittee; Professional Staff, Ways and Means Health Subcommittee; Health Policy Aide, Rep. Nancy Johnson; Legislative Assistant, Rep. Jim Ramstad
Thomas Scully Administrator & Consultant, CMS; Dep. Asst. to President; Counselor to the Dir., Dir. for Hum. Res. Vets and Labor; Associate Dir. for Legislative Affairs, OMB
Colin Roskey Health Policy Advisor and Counsel, Senate Finance Committee
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, FEDERAL HEALTH POLICY STRATEGIES lobbied for UPMC , earning $90,000. The report was filed on April 22.
Original Filing: 301572206.xml
Lobbying Issues
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to cancer treatment and radiation oncology.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to cancer treatment and radiation oncology.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, FEDERAL HEALTH POLICY STRATEGIES lobbied for UPMC , earning $90,000. The report was filed on Jan. 22.
Original Filing: 301538380.xml
Lobbying Issues
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, FEDERAL HEALTH POLICY STRATEGIES lobbied for UPMC , earning $90,000. The report was filed on Oct. 20, 2023.
Original Filing: 301514228.xml
Lobbying Issues
Issues related to CMS proposed rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedy rules; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to CMS proposed rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedy rules; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, FEDERAL HEALTH POLICY STRATEGIES lobbied for UPMC , earning $90,000. The report was filed on July 20, 2023.
Original Filing: 301490184.xml
Lobbying Issues
Issues related to inpatient prospective payment system (IPPS) proposed rule; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to hospital-based outpatient department (HOPD) 340B remedy proposed rule; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to inpatient prospective payment system (IPPS) proposed rule; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to hospital-based outpatient department (HOPD) 340B remedy proposed rule; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials.
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, FEDERAL HEALTH POLICY STRATEGIES lobbied for UPMC , earning $90,000. The report was filed on April 20, 2023.
Original Filing: 301465770.xml
Lobbying Issues
Issues related to CMS inpatient hospital prospective payment system proposed rule development; issues related to House Energy and Commerce Committee hearings on heath care transparency; isssues related to CMS Advance Notice of Methodological Changes and Parts C & D Capitation Rates for 2024; issues related to CMS proposed rule relating to policy and technical changes to Medicare Advantage and Prescription Drug Programs; issues related to pending expiration of COVID-19 Public Health Emergency.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to CMS inpatient hospital prospective payment system proposed rule development; issues related to House Energy and Commerce Committee hearings on heath care transparency; isssues related to CMS Advance Notice of Methodological Changes and Parts C & D Capitation Rates for 2024; issues related to CMS proposed rule relating to policy and technical changes to Medicare Advantage and Prescription Drug Programs; issues related to pending expiration of COVID-19 Public Health Emergency.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, FEDERAL HEALTH POLICY STRATEGIES lobbied for UPMC , earning $90,000. The report was filed on Jan. 20, 2023.
Original Filing: 301440938.xml
Lobbying Issues
H.R. 5376, Inflation Reduction Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund; S. 1568/H.R. 4407 TRAIN Act
H.R. 4040, Advancing Telehealth Beyond COVID-19 ActH.R. 2167, Consolidated Appropriations Act of 2023
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 5376, Inflation Reduction Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund; S. 1568/H.R. 4407 TRAIN Act
H.R. 4040, Advancing Telehealth Beyond COVID-19 Act
H.R. 2167, Consolidated Appropriations Act of 2023
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, FEDERAL HEALTH POLICY STRATEGIES lobbied for UPMC , earning $90,000. The report was filed on Oct. 20, 2022.
Original Filing: 301416623.xml
Lobbying Issues
H.R. 5376, Inflation Reduction Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund; S. 1568/H.R. 4407 TRAIN Act
H.R. 4040, Advancing Telehealth Beyond COVID-19 Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 5376, Inflation Reduction Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund; S. 1568/H.R. 4407 TRAIN Act
H.R. 4040, Advancing Telehealth Beyond COVID-19 Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, FEDERAL HEALTH POLICY STRATEGIES lobbied for UPMC , earning $90,000. The report was filed on July 20, 2022.
Original Filing: 301393597.xml
Lobbying Issues
H.R. 5376, Build Back Better Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund; S. 1568/H.R. 4407 TRAIN Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 5376, Build Back Better Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund; S. 1568/H.R. 4407 TRAIN Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, FEDERAL HEALTH POLICY STRATEGIES lobbied for UPMC , earning $90,000. The report was filed on April 20, 2022.
Original Filing: 301368564.xml
Lobbying Issues
H.R. 5376, Build Back Better Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund; S. 610 Protecting Medicare and American Farmers from Sequester Cuts Act; H.R. 2471, Consolidated Appropriations Act, 2022; H.R. 4407/S. 1568 TRAIN Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 5376, Build Back Better Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund; S. 610 Protecting Medicare and American Farmers from Sequester Cuts Act; H.R. 2471, Consolidated Appropriations Act, 2022; H.R. 4407/S. 1568 TRAIN Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, FEDERAL HEALTH POLICY STRATEGIES lobbied for UPMC , earning $90,000. The report was filed on Jan. 20, 2022.
Original Filing: 301334101.xml
Lobbying Issues
H.R. 5376, Build Back Better Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund; S. 610 Protecting Medicare and American Farmers from Sequester Cuts Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 5376, Build Back Better Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund; S. 610 Protecting Medicare and American Farmers from Sequester Cuts Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, FEDERAL HEALTH POLICY STRATEGIES lobbied for UPMC , earning $40,000. The report was filed on Oct. 20, 2021.
Original Filing: 301310949.xml
Lobbying Issues
H.R. 5376, Build Back Better Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 5376, Build Back Better Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
FEDERAL HEALTH POLICY STRATEGIES filed a lobbying registration on Sept. 15, 2021 to represent UPMC, effective Aug. 1, 2021.
Original Filing: 301295399.xml
Issue(s) they said they’d lobby about: Medicare billing issues
Medicare legislative and regulatory issues .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...